Randomised clinical trial: the safety and efficacy of AST-120 in non-constipating irritable bowel syndrome - a double-blind, placebo-controlled study.
about
The role of AST-120 and protein-bound uremic toxins in irritable bowel syndrome: a therapeutic perspectivePharmacological agents currently in clinical trials for disorders in neurogastroenterology.Ammonia-lowering strategies for the treatment of hepatic encephalopathy.New treatments for IBS.Current and future pharmacological treatments for diarrhea-predominant irritable bowel syndrome.Histamine and gut mucosal immune regulation.Treatment of abdominal pain in irritable bowel syndrome.Emerging drug for diarrhea predominant irritable bowel syndrome.New and Investigational Agents for Irritable Bowel Syndrome.Targeting Histamine Receptors in Irritable Bowel Syndrome: A Critical Appraisal.New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond.Glioplasticity in irritable bowel syndrome.Efficacy of AST-120 in dogs with chronic idiopathic enteropathies.Does the oral adsorbent AST-120 really improve symptoms for non-constipating irritable bowel syndrome?Carbon-based compounds emerging as sparkling diamonds for IBS treatment?
P2860
Q26795563-AC76F9C3-2C4E-4DD3-BD24-59121C3F2C3AQ37200907-CFEC4991-C955-456E-B70B-4113C28FB3F6Q38032730-CE19D1D7-850A-4C64-8291-69C2F349C360Q38059436-F11C85D2-A3C5-4E8C-85D8-6A0E0F2AC1FAQ38102063-BEF8F8FC-0B67-45CF-9A85-5DDCFCB4CBEFQ38167039-14586B36-FCD7-4F7F-9DCB-B5C1FCB58642Q38213185-AF75B62A-6865-48FE-A443-E32B94039648Q38366814-DFC81E7B-A523-4D95-B6D5-4F068CFC2F8DQ38601834-46AA1CCF-9526-4CEB-B593-08D1BAE947B9Q39334633-0DADA491-5664-43DE-8964-BC9E2C5A076DQ42695148-F84C9627-CF2C-4CBB-83F7-E21218939C21Q48020961-DBA12F67-F5FA-4542-BC78-D9EC1CD9EB70Q52882163-8AD23F2A-2BF0-40D2-A302-3DADAB0D6FFBQ57107053-7F6D804F-D6EF-455B-B93E-800FB757B9BDQ57789403-DEE4A0EA-F702-4907-9852-E54E60C05A0F
P2860
Randomised clinical trial: the safety and efficacy of AST-120 in non-constipating irritable bowel syndrome - a double-blind, placebo-controlled study.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Randomised clinical trial: the ...... ind, placebo-controlled study.
@en
Randomised clinical trial: the ...... ind, placebo-controlled study.
@nl
type
label
Randomised clinical trial: the ...... ind, placebo-controlled study.
@en
Randomised clinical trial: the ...... ind, placebo-controlled study.
@nl
prefLabel
Randomised clinical trial: the ...... ind, placebo-controlled study.
@en
Randomised clinical trial: the ...... ind, placebo-controlled study.
@nl
P2093
P2860
P1476
Randomised clinical trial: the ...... ind, placebo-controlled study.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2036.2011.04818.X
P407
P577
2011-08-24T00:00:00Z